在印度的thalidomide的历史
Ludger Wimmelbücker1, Anita Kar2
1Institute for the History of Medicine and Ethics in Medicine, Charité - University Medicine Berlin, Thielallee 71, 14195Berlin, Germany.
Medical history
|September 5, 2023
概括
thalidomide在1960年左右进入印度,这与之前的假设相反. 殖民历史影响了它的早期使用和麻风的重新出现,复杂的监管和分布途径影响了出生缺陷风险.
科学领域:
- 医学史 医学史 的历史
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 在全球范围内,thalidomide的致性作用得到了充分的证据.
- 有限的历史数据存在关于thalidomide在2002年之前在印度的存在和使用.
- 这种药物在1965年以后的印度麻风治疗中重新出现的研究不足.
研究的目的:
- 调查印度的thalidomide的历史轨迹,挑战其在2002年之前存在的忽略不计的假设.
- 分析自20世纪60年代中期以来影响印度thalidomide的分布,使用和监管的因素.
- 在监管条款的背景下,评估印度的thalidomide诱导出生缺陷的当前风险.
主要方法:
- 泰利多米德在印度的引入和演变的历史分析.
- 考察殖民遗产对药物获取和监管的影响.
- 确定涉及印度thalidomide生命周期的关键利益相关者.
- 对当前的监管框架和出生缺陷监测系统进行批判性审查.
主要成果:
- 塔利多米德在1960年左右通过戈阿进入印度次大陆,早于官方营销许可证.
- 殖民历史在早期引入和后来重新出现麻风的thalidomide中发挥了重要作用.
- 主要参与者包括原始制造商,国际医疗专业人员,世卫组织和印度国家机构,影响分销和监管.
- 该研究强调了当今监管监督和出生缺陷监测方面的担忧.
结论:
- 泰利多米德在印度的历史比以前理解的更为广泛,早期的引入与殖民关系有关.
- 毒品的发展轨迹涉及国际和国家实体之间的复杂相互作用,影响其可用性和控制.
- 目前的监管措施和监测印度的thalidomide诱导的出生缺陷需要批判性评估,以减轻风险.
更多相关视频
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
12.7K
13:47Establishment of an In vitro System to Study Intracellular Behavior of Candida glabrata in Human THP-1 Macrophages
Published on: December 10, 2013
11.7K
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Pharmacovigilance
886
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
886
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
